Revvity Inc vs Tempus AI — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Tempus AI trades at $49.06 (market cap $8.69B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.26% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| RVTY | TEM | |
|---|---|---|
Market Cap | $11.87B | $8.69B |
Sector | Technology | Broad Market / Factor |
52-Week High | $117.75 | $103.25 |
52-Week Low | $82.26 | $42.37 |
Enterprise Value | $14.36B | $9.37B |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →